In addition to the above indicators, lower levels of superoxide dismutase (SOD), higher levels of fibrinogen degradation products (FDP) and C‐reactive protein (CRP), and a higher erythrocyte sedimentation rate (ESR) were also found in severe COVID‐19 patients in the clinical recovery stage. The gene discussed is SOD1; the disease is COVID-19.